Rx risk communication meeting
Executive Summary
FDA public meeting to seek input on the agency's risk communication mechanisms is slated for Dec. 7-8. Discussion topics include patient information sheets, health care professional sheets, talk papers, public health advisories, CDER's educational campaigns and website. The meeting will be held at the National Transportation Safety Board boardroom and conference center in Washington, D.C. (1"The Pink Sheet" Sept. 19, 2005, p. 18)...
You may also be interested in...
FDA Public Meeting On Rx Risk, Benefit Communication Slated For December
FDA will hold a public hearing on ways to better communicate information about drug risks and benefits, FDA Drug Safety Oversight Board Executive Director Susan Cummins said at the PDA/FDA Joint Regulatory Conference in Washington, D.C. on Sept. 13
Behavioral Health Company Two Chairs Secures $72M In Equity And Debt Infusion
Two Chairs, which uses algorithms to match the right therapists with patients, secured $72m in investment to expand its business.
Teva Says The Time Is Right For Two Big Immunology Biosimilar Launches
US market access senior VP Tom Rainey talks to Scrip about the upcoming launches of biosimilar versions of Humira and Stelara.